美国 · SEC FORM 4
GUIDED THERAPEUTICS INC
GTHP · OTC · CIK 0000924515 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
0 同一窗口内观察到的 Form 4 交易行
0 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
当前 180 天窗口内没有 Form 4 交易事件。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-29 · Grujic Alan.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,727
- 上期报告
- 6,822
- 日均成交量
- 127,857
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-08-29 | JAMES MICHAEL C | 买入 (P) | Common Stock | 27,778 | USD 0.18 | USD 5,000 | SEC 申报 ↗ |
| 2025-08-29 | Imhoff John E | 买入 (P) | Common Stock | 166,667 | USD 0.18 | USD 30,000 | SEC 申报 ↗ |
| 2025-08-29 | Grujic Alan | 买入 (P) | Common Stock | 152,108 | USD — | USD — | SEC 申报 ↗ |
| 2025-03-18 | Imhoff John E | 买入 (P) | Common Stock | 1,263,069 | USD 0.10 | USD 126,307 | SEC 申报 ↗ |
| 2025-03-18 | Imhoff John E | 买入 (P) | Common Stock | 1,263,069 | USD 0.10 | USD 126,307 | SEC 申报 ↗ |
| 2025-03-18 | JAMES MICHAEL C | 买入 (P) | Common Stock | 412,945 | USD 0.10 | USD 41,294 | SEC 申报 ↗ |
| 2025-03-13 | Imhoff John E | 买入 (P) | Preferred Series E Stock | 150 | USD — | USD — | SEC 申报 ↗ |
| 2025-03-07 | Imhoff John E | 买入 (P) | Preferred Series C Stock | 286 | USD — | USD — | SEC 申报 ↗ |
| 2025-03-07 | Imhoff John E | 买入 (P) | Preferred Series C Stock | 286 | USD — | USD — | SEC 申报 ↗ |
| 2024-12-18 | Imhoff John E | 买入 (P) | Common Stock | 1,615,385 | USD — | USD — | SEC 申报 ↗ |
| 2024-09-23 | Imhoff John E | 买入 (P) | Common Stock | 1,666,667 | USD — | USD — | SEC 申报 ↗ |
| 2023-08-11 | Imhoff John E | 买入 (P) | Common Stock | 500,899 | USD — | USD — | SEC 申报 ↗ |
| 2022-09-02 | Blumberg Richard P. | 买入 (P) | Common Stock | 1,000,000 | USD — | USD — | SEC 申报 ↗ |
| 2022-09-02 | Imhoff John E | 买入 (P) | Common Stock | 500,000 | USD — | USD — | SEC 申报 ↗ |
| 2022-09-02 | JAMES MICHAEL C | 买入 (P) | Common Stock | 100,000 | USD — | USD — | SEC 申报 ↗ |
Form 4 申报证据
8 transaction lines in the latest 365-day window; 75 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-02-27 | Imhoff John E | J (J) | Preferred Series E Stock | 100 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-27 | Imhoff John E | J (J) | Common Stock | 400,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-27 | Imhoff John E | C (C) | Common Stock | 156,086 | USD 0.07 | USD 10,926 | SEC 申报 ↗ |
展开近期 Form 4 证据 (8 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-02-27 | Imhoff John E | J (J) | Preferred Series E Stock | 100 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-27 | Imhoff John E | J (J) | Common Stock | 400,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-27 | Imhoff John E | C (C) | Common Stock | 156,086 | USD 0.07 | USD 10,926 | SEC 申报 ↗ |
| 2026-02-25 | Imhoff John E | X (X) | Common Stock | 500,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-25 | JAMES MICHAEL C | X (X) | Common Stock | 100,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-02 | Imhoff John E | C (C) | Common Stock | 312,720 | USD 0.07 | USD 21,890 | SEC 申报 ↗ |
| 2026-01-05 | Imhoff John E | J (J) | Common Stock | 25,338 | USD — | USD — | SEC 申报 ↗ |
| 2025-12-18 | Imhoff John E | C (C) | Common Stock | 195,460 | USD 0.07 | USD 13,682 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | GTHP |
| CIK | 0000924515 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3845 Electromedical & Electrotherapeutic Apparatus |
| 交易所 | OTC |
数据覆盖
| 本地 Form 4 历史 | 75 transaction lines from 2022-09-02 to 2026-02-27 18 P purchase lines · 0 S sale lines · 57 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.